Promoter acquires 36,68,036 shares (15.89% stake) from its wholly owned subsidiary in group restructuring

Sudarshan Chemical Industries Ltd, a promoter of the target company, has acquired 36,68,036 equity shares (15.89% of the equity share capital) from Sudarshan Europe B.V., also a promoter and its wholly owned subsidiary.

Mon 5 Oct 2026

Shares Acquired

36,68,036 equity shares (15.89% of the equity share capital)

Aggregate Consideration

INR 150,75,62,796/-

Price Per Share

INR 411/- per equity share

Acquirer Holding Change

0 shares (0.00%) to 36,68,036 shares (15.89%)

Consolidated Promoter Group Holding

no change in the consolidated total shareholding of the promoter and promoter group

What the disclosure records

• The update is a disclosure under Regulation 10(6) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, made to BSE Limited and the National Stock Exchange of India Limited.
• Sudarshan Chemical Industries Limited, a promoter of the target company, has acquired 36,68,036 equity shares of the target company, representing 15.89% of its equity share capital.
• The seller is Sudarshan Europe B.V., a promoter of the target company and a wholly owned subsidiary of the acquirer.

Price paid

• The update records an aggregate consideration of INR 150,75,62,796/-, which amounts to INR 411/- per equity share.

Who holds what

• Acquirer (Sudarshan Chemical Industries Limited): 0 shares (0.00%) before the transaction; 36,68,036 shares (15.89%) after.
• Seller (Sudarshan Europe B.V.): 36,68,036 shares (15.89%) before; 0 shares (0.00%) after.
• Sudarshan Switzerland HLD1 AG (a person acting in concert): 84,39,385 shares (36.56%) before and after.
• Sudarshan Switzerland HLD2 AG (a person acting in concert): 41,09,426 shares (17.80%) before and after.
• Combined figure for the acquirer and persons acting in concert, other than the seller: 1,25,48,811 shares (54.36%) before the transaction and 1,62,16,847 shares (70.26%) after.

How to read those two percentages

• The pre-transaction column is captioned for the acquirer, transferee and persons acting in concert other than the seller, so the 15.89% block standing in the seller's name is shown separately.
• After the transfer, that block sits in the acquirer's name and is counted inside the group total, moving the group column from 54.36% to 70.26%.
• The update states that as a result of the acquisition there is no change in the consolidated total shareholding of the promoter and promoter group in the target company.

Other points recorded in the update

• The acquisition is described as a measure towards internal restructuring of shareholding within the Sudarshan Chemical Group.
• The acquirer relies on the exemption in Regulation 10(1)(a)(iii) of the SEBI SAST Regulations from making an open offer.
• A prior disclosure under Regulation 10(5) was required and was made on 17th August, 2026, stated to be within the specified timeline. The date of acquisition is given as on or after 24 August 2026, and the disclosure is signed at Pune and dated 1st October 2026.

What it means in simple terms

• A block of shares has changed hands between two entities that are both part of the promoter group, and one of them is the wholly owned subsidiary of the other. It is a change in the name in which the block is held rather than a sale to an outside buyer.
• The number of shares held by the promoter group as a whole is stated to be unchanged, so the transfer does not by itself alter who controls the target company.
• The action is a promoter-level shareholding reorganisation; the update sets out the transfer, the price and the resulting holdings.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.